Brazil: How has the Madrid Protocol been implemented and what next?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Brazil: How has the Madrid Protocol been implemented and what next?

Sponsored by

daniel-400px.png
握手をするビジネスウーマンとビジネスマン、締結、成約、契約

On October 2 2019, Brazil joined the Madrid protocol. The success of this can be proven by numbers.

Until March 5 2020, 3,126 marks were designated to Brazil. The United States, the European market, China, Great Britain and Germany were the top filer countries. Thus far, most applications have come from well-established companies with worldwide reach, such as GSK, BMW, Syngenta Group, Apple, Luis Vuitton, Roche and others.

These numbers are expected to rise when the Protocol is fully implemented but, unfortunately, there are still important procedures pending including the multiclass system, co-ownership and division of applications/registrations. These procedures were scheduled to come into effect on March 9 2020 but were postponed indefinitely by the BPTO.

Another important point is the publication of international designations in the BPTO Official Bulletin.

In accordance with Brazilian law, all designations need to be locally published opening a 60 day term for the filing of oppositions, which are also published, opening another 60 days term for the filing of counterarguments. Up until now no publication has yet taken place which means that (1) applications filed within the protocol are likely to take much longer to be analysed than locally filed applications and (2) it is too early to anticipate the problems that these applications will encounter and how they will be analysed by the BPTO.

Furthermore, there is a catch concerning oppositions as they will only be published locally and will not be displayed on the WIPO portal which means that it is wise to have a local agent monitoring Brazilian designations.

Hiccups aside, once these problems are solved the Protocol will undoubtedly be an important tool to be used by companies to protect their trademark rights in Brazil.

more from across site and SHARED ros bottom lb

More from across our site

Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Gift this article